RT Journal Article
SR Electronic
T1 Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.03.20052688
DO 10.1101/2020.04.03.20052688
A1 Byrne, James D.
A1 Wentworth, Adam J.
A1 Chai, Peter R.
A1 Huang, Hen-Wei
A1 Babaee, Sahab
A1 Li, Canchen
A1 Becker, Sarah L.
A1 Tov, Caitlynn
A1 Min, Soekkee
A1 Traverso, Giovanni
YR 2020
UL http://medrxiv.org/content/early/2020/04/07/2020.04.03.20052688.abstract
AB There is a dire need for personal protective equipment (PPE) within healthcare settings during the COVID-19 pandemic. In particular, single use disposable N95 face masks have been limited in supply. We have developed an Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection. The iMASC system was designed as a reusable liquid silicone rubber mask with disposable N95 filter cartridges that can fit most face sizes and shapes. This system reduced the amount of N95 filter while preserving breathability and fit. Using finite element analysis, we demonstrated mask deformation and reaction forces from facial scans of twenty different wearers. In addition, we validated these findings by successful fit testing in twenty participants in a prospective clinical trial. The iMASC system has the potential to protect our healthcare workers with a reusable N95-comparable face mask that is rapidly scalable.Competing Interest StatementThere are no competing interests related to the work described in the manuscript. Complete details of all other relationships for profit and not for profit for G.T. can found at the following link: https://www.dropbox.com/sh/szi7vnr4a2ajb56/AABs5N5i0q9AfT1IqIJAE-T5a?dl=0Funding StatementFunding: J.B. was supported by the Prostate Cancer Foundation Young Investigator Award. G.T. was supported in part by the Department of Mechanical Engineering, MIT and Brigham and Women’s Hospital. P.R.C was supported by NIHK23DA044874, and investigator-initiated research grants from e-ink corporation, Gilead Sciences, Philips Biosensing and the Hans and Mavis Lopater Psychosocial Foundation. Suppport for the materials and supplies was from discretionary funds to G.T. from Brigham and Women’s Hospital and the Department of Mechanical Engineering, MIT.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available in the manuscript and the supplementary materials. https://imasc.mit.edu